Immunohistochemistry was performed for PD-L1 (clone SP263) with 51.4% tumor proportion score (TPS) and 77.1% combined proportion score (CPS), which was assessed at a cut-off of ≥1%. The gene discussed is CD274; the disease is neoplasm.